Tarsus Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARS and other ETFs, options, and stocks.About TARS
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis.
CEOBobak Azamian
CEOBobak Azamian
Employees323
Employees323
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded2017
Founded2017
Employees323
Employees323
TARS Key Statistics
Market cap3.17B
Market cap3.17B
Price-Earnings ratio-37.16
Price-Earnings ratio-37.16
Dividend yield—
Dividend yield—
Average volume534.59K
Average volume534.59K
High today$76.38
High today$76.38
Low today$74.18
Low today$74.18
Open price$76.01
Open price$76.01
Volume323.30K
Volume323.30K
52 Week high$76.81
52 Week high$76.81
52 Week low$38.51
52 Week low$38.51
Stock Snapshot
As of today, Tarsus Pharmaceuticals(TARS) shares are valued at $75.40. The company's market cap stands at 3.17B, with a P/E ratio of -37.16.
On 2025-11-13, Tarsus Pharmaceuticals(TARS) stock traded between a low of $74.18 and a high of $76.38. Shares are currently priced at $75.40, which is +1.6% above the low and -1.3% below the high.
Tarsus Pharmaceuticals(TARS) shares are trading with a volume of 323.3K, against a daily average of 534.59K.
In the last year, Tarsus Pharmaceuticals(TARS) shares hit a 52-week high of $76.81 and a 52-week low of $38.51.
In the last year, Tarsus Pharmaceuticals(TARS) shares hit a 52-week high of $76.81 and a 52-week low of $38.51.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own TARS. This list is generated using Robinhood data, and it’s not a recommendation.